Blog Posts - Type 2 Diabetes Mellitus



Diabetes mellitus

Diabetes mellitus is the metabolic disorder characterized by high blood glucose (sugar) level caused by decreased produce of insulin from pancreas or due to diminished effectiveness of insulin to the body (insulin resistance). Diabetes is the most c...
by emedicinezone on Apr 1, 2016

Histopathology Pancreas –Type 2 Diabetes mellitus

Histopathology Pancreas –Type 2 Diabetes mellitus...
by Diabetes Away on Oct 17, 2012

No Proven Added Benefit Of Linagliptin

Drug manufacturer deviates from appropriate comparator therapy specified by the G-BA Linagliptin (trade name: Trajenta®) has been approved since August 2011 to improve blood glucose control (“glycaemic control”) in adults with type 2 dia...

PANORAMA: A European study to evaluate quality of life and treatment satisfaction in patients with type-2 diabetes mellitus—Study design

Abstract: Aim: Type-2 diabetes mellitus (T2DM) is a major cause of disability reaching epidemic proportions worldwide. The disease burden of T2DM is commonly characterised using health status measures, but few European-wide data are available concern...

Diabetes Mellitus

Diabetes mellitus is the metabolic disorder characterized by high blood glucose (sugar) level caused...
by emedicinezone on Oct 20, 2011

Vitamin D Could Lower Risk Of Developing Type 2 Diabetes

Scientists at the Helmholtz Zentrum München have shown that people with a good vitamin D supply are at lower risk of developing type 2 diabetes mellitus. The study, which was conducted in cooperation with the German diabetes Center and the …...

The evaluation and management of childhood type 2 diabetes mellitus

Abstract: diabetes in children is increasing in prevalence with obesity-associated insulin resistance being a major contributing factor. This report contains a comprehensive review of treatment paradigms regarding the management of diabetes in childr...

Fracture Prediction Methods May Be Useful For Patients With Diabetes

Use of established fracture prediction methods in older patients with type 2 diabetes mellitus (DM) found that scores from these methods were associated with hip and nonspine fracture risk, and a certain score associated with higher risk of fracture...

Foundation For The NIH Launches Trial To Develop Diabetes Diagnostic Tools

The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium announced today the launch of a multi-year clinical study to improve tools for measuring the function of insulin-producing beta cells in people with type 2 diabetes mel...

Foundation For The NIH Launches Trial To Develop Diabetes Diagnostic Tools

The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium announced today the launch of a multi-year clinical study to improve tools for measuring the function of insulin-producing beta cells in people with type 2 diabetes mel...

Management of infections in type 2 diabetes from the patient’s perspective: A qualitative approach

Abstract: Aim: To explore the knowledge, and health beliefs of patients with type 2 diabetes mellitus (T2DM) regarding management of infections of the urinary tract (UTIs) and lower respiratory tract (LRTIs).Methods: Three semi-structured focus group...

FDA Accepts New Drug Application For Investigational Compound Dapagliflozin For The Treatment Of Type 2 Diabetes

Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for dapagliflozin, an investigational compound for the treatment of a...

Gene Variations Associated With Risk Of Type 2 Diabetes

For individuals of white European descent, certain variations of the gene HMGA1 are associated with type 2 diabetes mellitus, according to a study in the March 2 issue of JAMA… <a href="http://www.medicalnewstoday.com/rss/diabetes.xml&#...

KOMBIGLYZE™ XR Tablets, A New Treatment For Type 2 Diabetes Mellitus In Adults, Now Available In U.S. Pharmacies

Bristol-Myers Squibb Company (NYSE: BMY), and AstraZeneca (NYSE: AZN) today announced that KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release), approved by the U.S. Food and Drug Administration (FDA) on November 5, 2010, is now availabl...

Santarus And Depomed Announce Availability Of GLUMETZA 500 Mg Tablets

Santarus, Inc. (NASDAQ: SNTS) and Depomed, Inc. (NASDAQ: DEPO) announced that supply of GLUMETZA® 500 mg (metformin HCl extended release tablets) to wholesalers and retailers has resumed. GLUMETZA is a once-daily, extended release formulation of met...

Rosiglitazone (Avandia) and rosiglitazone with metformin (Avandamet) for type 2 diabetes mellitus

PBS listing Authority required (streamlined) Rosiglitazone (Avandia) may be used in patients with diabetes type 2 whose blood sugar concentrations are inadequately controlled (HbA 1c > 7%) as dual oral therapy with metformin or perhaps a sulfonyl...

Exercise: Your RIPPNESS Is Counting On It

Did you know that everything that gets you moving can and will contribute to your health--from walking to a high-intensity aerobics class?


Trending Topics

Close